Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
A logo A
Upturn stock ratingUpturn stock rating
A logo

Agilent Technologies Inc (A)

Upturn stock ratingUpturn stock rating
$124.96
Last Close (24-hour delay)
Profit since last BUY0%
upturn advisory
Consider higher Upturn Star rating
BUY since 1 day
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: A (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

20 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $138.17

1 Year Target Price $138.17

Analysts Price Target For last 52 week
$138.17 Target price
52w Low $96.23
Current$124.96
52w High $153.19

Analysis of Past Performance

Type Stock
Historic Profit -25.49%
Avg. Invested days 29
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 35.50B USD
Price to earnings Ratio 29.13
1Y Target Price 138.17
Price to earnings Ratio 29.13
1Y Target Price 138.17
Volume (30-day avg) 20
Beta 1.22
52 Weeks Range 96.23 - 153.19
Updated Date 08/28/2025
52 Weeks Range 96.23 - 153.19
Updated Date 08/28/2025
Dividends yield (FY) -
Basic EPS (TTM) 4.29

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-19
When Before Market
Estimate 1.37
Actual 1.37

Profitability

Profit Margin 17.59%
Operating Margin (TTM) 23.56%

Management Effectiveness

Return on Assets (TTM) 8.46%
Return on Equity (TTM) 18.88%

Valuation

Trailing PE 29.13
Forward PE 19.16
Enterprise Value 35724642566
Price to Sales(TTM) 5.36
Enterprise Value 35724642566
Price to Sales(TTM) 5.36
Enterprise Value to Revenue 5.39
Enterprise Value to EBITDA 20.31
Shares Outstanding 284064992
Shares Floating 283056298
Shares Outstanding 284064992
Shares Floating 283056298
Percent Insiders 0.29
Percent Institutions 92.32

ai summary icon Upturn AI SWOT

Agilent Technologies Inc

stock logo

Company Overview

overview logo History and Background

Agilent Technologies Inc. was founded in 1999 as a spin-off from Hewlett-Packard. It quickly established itself as a leader in life sciences, diagnostics, and applied chemical markets.

business area logo Core Business Areas

  • Life Sciences and Applied Markets Group (LSAG): Provides application-focused solutions that include instruments and software, primarily for the life science and applied chemical markets.
  • Diagnostics and Genomics Group (DGG): Offers diagnostic and genomic solutions, primarily for the clinical and diagnostic markets.
  • Agilent CrossLab Group (ACG): Provides services, consumables, and software to support the installed base across all of Agilentu2019s product lines.

leadership logo Leadership and Structure

Padraig McDonnell is the current CEO. Agilent has a functional organizational structure with centralized departments and business groups focused on specific markets.

Top Products and Market Share

overview logo Key Offerings

  • Liquid Chromatography Mass Spectrometry (LC/MS): LC/MS instruments are used for identifying and quantifying compounds in various samples. Agilent is a leading player in this market. Market share varies by specific LC/MS segment, but is estimated to be in the 20-30% range. Competitors include Thermo Fisher Scientific (TMO) and Waters Corporation (WAT).
  • Gas Chromatography (GC): GC instruments are used for separating and analyzing volatile compounds. Agilent holds a significant market share in GC, estimated between 30-40%. Competitors include Thermo Fisher Scientific (TMO) and PerkinElmer (PKI).
  • Genomics Solutions: Agilent's genomics solutions include microarrays, next-generation sequencing (NGS) library preparation, and target enrichment. Market share in genomics is more fragmented, but Agilent holds a significant position with revenues greater than 5% of total market. Competitors include Illumina (ILMN) and Thermo Fisher Scientific (TMO).

Market Dynamics

industry overview logo Industry Overview

The analytical instrument industry is driven by increasing demand for testing and analysis in life sciences, diagnostics, environmental monitoring, and food safety. Growth is also fueled by technological advancements and increasing regulatory requirements.

Positioning

Agilent is a leading provider of analytical instruments and solutions. Its competitive advantages include a broad product portfolio, strong brand reputation, and global reach.

Total Addressable Market (TAM)

The total addressable market for analytical instruments is estimated to be around $60 billion. Agilent is positioned to capture a significant portion of this TAM through its diverse product offerings and strategic acquisitions.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Broad product portfolio
  • Global reach
  • Innovation in analytical instruments
  • Recurring revenue from services and consumables

Weaknesses

  • High R&D expenses
  • Dependence on specific markets
  • Exposure to economic cycles
  • Complex product portfolio can create internal inefficiencies.

Opportunities

  • Growing demand for diagnostics and genomics
  • Expansion into emerging markets
  • Development of new technologies
  • Strategic acquisitions to expand product offerings

Threats

  • Intense competition
  • Technological obsolescence
  • Economic downturns
  • Changes in regulatory requirements

Competitors and Market Share

competitor logo Key Competitors

  • Thermo Fisher Scientific (TMO)
  • Danaher Corporation (DHR)
  • Waters Corporation (WAT)

Competitive Landscape

Agilent competes with a variety of companies in the analytical instrument market. Its competitive advantages include a broad product portfolio, strong brand reputation, and global reach. However, it faces intense competition from larger and more diversified players like Thermo Fisher Scientific.

Major Acquisitions

Resolution Bioscience

  • Year: 2021
  • Acquisition Price (USD millions): 550
  • Strategic Rationale: Expanded Agilent's presence in the NGS-based cancer diagnostics market.

BioTek Instruments

  • Year: 2019
  • Acquisition Price (USD millions): 1050
  • Strategic Rationale: Expanded Agilent's cell analysis portfolio and increased its presence in the drug discovery market.

Growth Trajectory and Initiatives

Historical Growth: Agilent has experienced steady growth in recent years, driven by strong demand in its core markets and successful execution of its growth strategy.

Future Projections: Analysts project continued growth for Agilent, driven by increasing demand for analytical instruments and solutions. Revenue growth is expected to be in the mid-single digits, with continued margin expansion.

Recent Initiatives: Recent strategic initiatives include acquisitions to expand product offerings, investments in R&D to develop new technologies, and expansion into emerging markets.

Summary

Agilent is a strong company with a leading position in the analytical instrument market. It benefits from a broad product portfolio, strong brand reputation, and recurring revenue streams. While facing competition, its focus on innovation and strategic acquisitions positions it well for future growth. A key area to watch is its ability to maintain margins in a competitive environment.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Agilent Technologies Inc. Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Industry Reports (e.g., BCC Research, MarketsandMarkets)
  • Analyst Reports (e.g., Morgan Stanley, Goldman Sachs)

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Agilent Technologies Inc

Exchange NYSE
Headquaters Santa Clara, CA, United States
IPO Launch date 1999-11-18
CEO, President & Director Mr. Padraig McDonnell
Sector Healthcare
Industry Diagnostics & Research
Full time employees 18000
Full time employees 18000

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.